Product
M4
1 clinical trial
2 indications
Indication
HIVIndication
HIV-1 infectionClinical trial
IGHID 12107 - A Phase I Study to Evaluate the Safety and Immunogenicity of the ChAdOx1.HIVconsv62 - MVA.tHIVconsv4 (C62-M4) or, ChAdOx1.tHIVconsv1+C62 - MVA.tHIVconsv3+M4 (C1C62-M3m4) PRIME-BOOST REGIMENS in Persons With HIV-1 Suppressed on Antiretroviral Therapy - The CM (HIV-Core 008) StudyStatus: Recruiting, Estimated PCD: 2024-05-01